Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors
Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors
Recruiting · NCT05599048 · Registry updated 2026-05-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Hyperpolarized 13C MRI as a Biomarker in Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 / Phase 2 | 2026-05-27 | NCT05599048 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| National Institute for Biomedical Imaging and Bioengineering (NIBIB) | 47 |
| Robert Bok, MD, PhD | 2 |
| Sigma-Aldrich | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of California, San Francisco | San Francisco | United States | 294 |